Richard J. Stebbings

Clinical Pharmacology And Safety Sciences R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics.

Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics.

Journal: Regulatory toxicology and pharmacology : RTP

Published: April 03, 2025

An In Vitro Human Skin Test for Predicting Skin Sensitization and Adverse Immune Reactions to Biologics.

An In Vitro Human Skin Test for Predicting Skin Sensitization and Adverse Immune Reactions to Biologics.

Journal: Toxics

Published: February 01, 2024

Report from an ICT 2022 workshop on toxicology for Covid19 vaccines: Industry, regulatory and CRO perspectives.

Report from an ICT 2022 workshop on toxicology for Covid19 vaccines: Industry, regulatory and CRO perspectives.

Journal: Vaccine

Published: May 15, 2023

Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice.

Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice.

Journal: Frontiers in immunology

Published: November 25, 2022

A Consideration of Fixed Dosing Versus Body Size-Based Dosing Strategies for Chimeric Antigen Receptor T-Cell Therapies.

A Consideration of Fixed Dosing Versus Body Size-Based Dosing Strategies for Chimeric Antigen Receptor T-Cell Therapies.

Journal: Clinical pharmacology in drug development

Published: June 25, 2022

SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19).

SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19).

Journal: Frontiers in immunology

Published: December 15, 2021

AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.

AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.

Journal: Vaccine

Published: July 23, 2021

Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice.

Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: May 19, 2021

Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy-induced cytokine release syndrome.

Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy-induced cytokine release syndrome.

Journal: Clinical & translational immunology

Published: July 07, 2020

Development of the first reference antibody panel for qualification and validation of cytokine release assay platforms - Report of an international collaborative study.

Development of the first reference antibody panel for qualification and validation of cytokine release assay platforms - Report of an international collaborative study.

Journal: Cytokine: X

Published: May 04, 2020

Recent Advancements and Applications of Human Immune System Mice in Preclinical Immuno-Oncology.

Recent Advancements and Applications of Human Immune System Mice in Preclinical Immuno-Oncology.

Journal: Toxicologic pathology

Published: December 19, 2019

Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity.

Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity.

Journal: Vaccine

Published: October 30, 2019

Showing 1-12 of 40

Last Updated: 09/26/2026